HilleVax Attends Investor Conferences in November – HilleVax…
BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) — HilleVax, Inc. HLVXa clinical-stage biopharmaceutical company focused on the development and commercialization of novel vaccines, announced today that